Home > Blog

Blog | Veristat

Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.

Sign Up Today

Clinical Trials (3)

1 min read

Team Veristat Raised over $50K To Support Rare Cancer Research

Our Challenge:   Join the Battle to Beat Rare Cancers

Our Impact:   $150K Raised to Support Rare Cancer Research

For a fifth consecutive year, Team Veristat accepted this challenge in the 2019 Boston #cycleforsurvival event!   We exceeded our goal of raising

READ MORE

2 min read

More Seats at the Table | The Growth of Female Leadership in Healthcare

As a Talent Acquisition Consultant for Veristat, I receive many cover letters and resumes from candidates each day. I am often blown away by the experience, knowledge, and expertise of these individuals and always hope to match their skill sets to one of...

READ MORE

3 min read

What  to Know Before Considering an Adaptive Design Clinical Trial

The Food and Drug Administration (FDA) has started encouraging the use of adaptive designs for clinical studies. In essence, adaptive designs allow prospectively planned modifications to a clinical trial based on interim data, provided scientific...

READ MORE

3 min read

Flexibility is the Key to Data Acquisition for Rare Disease Trials

Understanding Why Creative Data Collection Solutions Are Necessary

READ MORE

2 min read

Delivering Smarter, Faster & Patient-Centric  Clinical Trials with Integrated Clinical Technologies

A Recap of the New York Medidata NEXT Event: Where Science Meets Technology Meets the Future

Kathleen Boruchowski, Associate Director of Data Management, attended the Medidata NEXTconference in New York City on November 8-10. The conference, which has...

READ MORE

2 min read

Competing Risk Analysis in Clinical Trials | A Practical Example

In pharmaceutical clinical trials, considering competing risk analyses is highly important. Competing risks are events that may occur and prevent the evaluation of a specific primary endpoint, in turn biasing risk estimations or drug efficacy. 

READ MORE

1 min read

Veristat Launches New eTMF System

To Improve Real-Time Visibility of Clinical Trial Documentation and Inspection-Readiness

Veristat has completed the validation and configuration of Master Control’s eTMF system, which is now implemented and available for Veristat managed clinical trials. 

READ MORE

2 min read

Veristat Pauses to Celebrate its Dedication to Making Lives Longer and Healthier

Just last week, in the midst of the daily chaos of building new clinical trial databases, working on impending regulatory submissions, holding project team meetings, and programing tables figures & listings, Veristat paused its operations for one day in...

READ MORE

2 min read

How to Select & Execute a Biomarker-Driven Clinical Trial Designs

At the 2016 Duke Industry Statistics Symposium, Dr. Robin Bliss, in collaboration with Dr. Jing Wang of Gilead Sciences, lead a discussion on “Biomarker-Driven Clinical Trial Designs for Precision Medicine.” Dr. Bliss highlighted two Adaptive Enrichment...

READ MORE

4 min read

What Are the Major/Common Types of Adaptive Designs Used in Clinical Trials Today?

An adaptive design is a clinical trial design that allows adaptations or modifications to aspects of the trial after its initiation without undermining the validity and integrity of the trial. An adaptive design consists of multiple stages. At each...

READ MORE